Kentaro Suina

687 total citations
20 papers, 375 citations indexed

About

Kentaro Suina is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kentaro Suina has authored 20 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Kentaro Suina's work include Lung Cancer Treatments and Mutations (7 papers), Cancer Cells and Metastasis (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Kentaro Suina is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer Cells and Metastasis (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Kentaro Suina collaborates with scholars based in Japan, United States and Netherlands. Kentaro Suina's co-authors include Hideyuki Saya, Osamu Nagano, Shogo Okazaki, Juntaro Yamasaki, Kiyoko Umene, Kazuhisa Takahashi, Fumiyuki Takahashi, Yuki Hirata, Naoko Shimada and Takashi Semba and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Annals of Oncology.

In The Last Decade

Kentaro Suina

18 papers receiving 373 citations

Peers

Countries citing papers authored by Kentaro Suina

Since Specialization

Citations

This map shows the geographic impact of Kentaro Suina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Suina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Suina more than expected).

Fields of papers citing papers by Kentaro Suina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Suina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Suina. The network helps show where Kentaro Suina may publish in the future.

Co-authorship network of co-authors of Kentaro Suina

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Suina. A scholar is included among the top collaborators of Kentaro Suina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Suina. Kentaro Suina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selective Depletion of Cancer Cells with Extrachromosomal DNA via Lentiviral Infection 2025 ·Cancer Research Communications ·Eunhee Yi, Amit D. Gujar, Dacheng Zhao, Kentaro Suina, Xue Jin, Katharina Pardon, (unknown), (unknown), (unknown), (unknown), Jef D. Boeke, Anton G. Henssen, Roel G.W. Verhaak	0
2	CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma 2023 ·Thoracic Cancer ·(unknown), Kentaro Suina, Takehito Shukuya, Fumiyuki Takahashi, Takuo Hayashi, Kieko Hara, Tsuyoshi Saito, Yoichiro Mitsuishi, (unknown), Wira Winardi, Ken Tajima, Ryo Ko, (unknown), Tetsuhiko Asao, Masayoshi Itoh, Hideya Kawaji, Yoshiyuki Suehara, Kazuya Takamochi, Kenji Suzuki, Kazuhisa Takahashi	6
3	Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer 2022 ·Biochemistry and Biophysics Reports ·Kenji Tsuchihashi, Yuki Hirata, Juntaro Yamasaki, Kentaro Suina, (unknown), Toshifumi Yae, Kenta Masuda, Eishi Baba, Koichi Akashi, Yuko Kitagawa, Hideyuki Saya, Osamu Nagano	1
4	MEK inhibition suppresses metastatic progression of KRAS‐mutated gastric cancer 2021 ·Cancer Science ·Juntaro Yamasaki, Yuki Hirata, (unknown), Kentaro Suina, Yoshiyuki Saito, Kenta Masuda, Shogo Okazaki, Takatsugu Ishimoto, Hideyuki Saya, Osamu Nagano	16
5	Lung Adenocarcinoma Mouse Models Based on Orthotopic Transplantation of Syngeneic Tumor-Initiating Cells Expressing EpCAM, SCA-1, and Ly6d 2020 ·Cancers ·Takashi Semba, Ryo Sato, Akiyoshi Kasuga, Kentaro Suina, Tatsuhiro Shibata, Takashi Kohno, Makoto Suzuki, Hideyuki Saya, Yoshimi Arima	10
6	Glutaminolysis‐related genes determine sensitivity to xCT‐targeted therapy in head and neck squamous cell carcinoma 2019 ·Cancer Science ·Shogo Okazaki, Kiyoko Umene, Juntaro Yamasaki, Kentaro Suina, (unknown), Momoko Yoshikawa, (unknown), Takashi Masuko, (unknown), Hideki Nakayama, Kouji Banno, Daisuke Aoki, Hideyuki Saya, Osamu Nagano	62
7	Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT‐targeted therapy 2019 ·Cancer Science ·(unknown), Juntaro Yamasaki, Kentaro Suina, Shogo Okazaki, Naoyoshi Koike, Hideyuki Saya, Osamu Nagano	22
8	Evidence for treatment with anti-PD-1 antibody for thymic cancer: how to identify patients most likely to benefit 2019 ·Shanghai Chest ·Kentaro Suina, Takehito Shukuya	0
9	Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B‐containing N‐methyl‐d‐aspartate–sensitive glutamate receptor signaling 2018 ·Cancer Science ·Kentaro Suina, Kenji Tsuchihashi, Juntaro Yamasaki, (unknown), (unknown), Yuki Hirata, Shogo Okazaki, Oltea Sampetrean, Eishi Baba, Koichi Akashi, Yoichiro Mitsuishi, Fumiyuki Takahashi, Kazuhisa Takahashi, Hideyuki Saya, Osamu Nagano	23
10	Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells 2018 ·Oncotarget ·Shogo Okazaki, (unknown), Yuki Hirata, Kentaro Suina, Takashi Semba, Juntaro Yamasaki, Kiyoko Umene, Miyuki Ishikawa, Hideyuki Saya, Osamu Nagano	62
11	Clinical features of squamous cell lung cancer with anaplastic lymphoma kinase (ALK)-rearrangement: a retrospective analysis and review 2018 ·Oncotarget ·Junko Watanabe, Shinsaku Togo, (unknown), Yukiko Namba, Kentaro Suina, (unknown), Kotaro Kadoya, (unknown), (unknown), Tetsutaro Nagaoka, Shinichi Sasaki, Takuo Hayashi, Toshimasa Uekusa, (unknown), Yasuo Urata, Fuminori Sakurai, Hiroyuki Mizuguchi, Shunsuke Kato, Kazuhisa Takahashi	19
12	Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407) 2017 ·Gastric Cancer ·Kohei Shitara, Toshihiko Doi, Osamu Nagano, Miki Fukutani, Hiromi Hasegawa, Shogo Nomura, Akihiro Sato, Takeshi Kuwata, Kai Asai, Yasuaki Einaga, Kenji Tsuchihashi, Kentaro Suina, Yusuke Maeda, Hideyuki Saya, Atsushi Ohtsu	47
13	The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc( 2016 ·Juntaro Yamasaki, Kenji Tsuchihashi, Kentaro Suina, Shogo Okazaki, Hideyuki Saya, Osamu Nagano	3
14	Loxoprofen-induced interstitial pneumonia: a case report 2016 ·Journal of Medical Case Reports ·Motoyasu Kato, Shinichi Sasaki, (unknown), (unknown), (unknown), Kentaro Suina, (unknown), Keiko Muraki, (unknown), Yasuko Yoshioka, Shigeru Tominaga, Kazuhisa Takahashi	1
15	Risk factors for serious adverse events due to cytotoxic chemotherapy for advanced non-small cell lung cancer 2016 ·Cancer Treatment and Research Communications ·Kentaro Suina, Takehito Shukuya, Ryo Koyama, Tetsuhiko Asao, (unknown), Motoyasu Kato, Keiko Muraki, (unknown), Naoko Shimada, Fumiyuki Takahashi, (unknown), Kazuhisa Takahashi	1
16	Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells 2016 ·Biochemical and Biophysical Research Communications ·Isao Kobayashi, Fumiyuki Takahashi, Fariz Nurwidya, Takeshi Nara, Muneaki Hashimoto, Akiko Murakami, Shigehiro Yagishita, Ken Tajima, Moulid Hidayat, Naoko Shimada, Kentaro Suina, Yasuko Yoshioka, Shinichi Sasaki, Mariko Moriyama, Hiroyuki Moriyama, Kazuhisa Takahashi	44
17	Dasatinib suppresses TGFβ-induced epithelial mesenchymal transition and inhibits pulmonary fibrosis 2014 ·European Respiratory Journal ·Motoyasu Kato, Fumiyuki Takahashi, Shigehiro Yagishita, Tetsuhiko Asao, (unknown), Kentaro Suina, (unknown), Fariz Nurwidya, Isao Kobayashi, Keiko Muraki, Tadashi Sato, Naoko Shimada, (unknown), Kazuhisa Takahashi	1
18	Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease 2014 ·BMC Cancer ·Motoyasu Kato, Takehito Shukuya, Fumiyuki Takahashi, Keita Mori, Kentaro Suina, Tetsuhiko Asao, (unknown), (unknown), Keiko Muraki, (unknown), (unknown), Ryo Koyama, Naoko Shimada, Kazuhisa Takahashi	37
19	Efficacy and Toxicity of Crizotinib for Patients with ALK-Positive Advanced NSCLC 2013 ·Annals of Oncology ·Tetsuhiko Asao, (unknown), Kentaro Suina, Keiko Muraki, (unknown), (unknown), Ryo Koyama, Naoki Shimada, (unknown), Kazuhisa Takahashi	1
20	Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer. 2013 ·Journal of Clinical Oncology ·Keiko Muraki, Ryo Koyama, Kentaro Suina, Tetsuhiko Asao, (unknown), Takehito Shukuya, Rina Ohashi, Naoko Shimada, Fumiyuki Takahashi, Kazuhisa Takahashi	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact